Compare Crocs, Inc. (CROX) vs Johnson & Johnson (JNJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Crocs, Inc. vs Johnson & Johnson — how do they compare? Crocs, Inc. trades at $131.61 (market cap $6.31B), while Johnson & Johnson trades at $259 (market cap $626.09B). The key difference: Johnson & Johnson is far larger — about 99.2× Crocs, Inc.'s market cap, and Johnson & Johnson pays a 2.06% dividend while Crocs, Inc. pays none. Which is the better fit depends on your goals.
| CROX | JNJ | |
|---|---|---|
Market Cap | $6.31B | $626.09B |
Sector | Consumer Staples | Health |
52-Week High | $141.19 | $267.24 |
52-Week Low | $73.39 | $172.78 |
Enterprise Value | $7.83B | $654.37B |
Volume | — | 6,156,228 |
Dividend Yield | — | 2.06% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Crocs, Inc.
Crocs Inc is engaged in the design, development, marketing, distribution, and sale of casual lifestyle footwear accessories for men, women, and children. The reportable geographic segments of the company include Americas, Asia pacific, and EMEA.
Read more on CROX →About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →
